Alpha-1 gene therapy safely tested in first three patients
GAINESVILLE, Fla. — A gene therapy to combat one of the most common hereditary disorders, alpha-1 antitrypsin deficiency, appears safe in the first three patients to participate in a landmark clinical trial, University of Florida researchers have found.
